CannabisNewsBreaks

WednesdayJul 24, 2019 10:04 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Manufacturing & Licensing Partnership with Hill Street Beverage Co. (TSX.V: BEER)

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies have entered into a 10-year Joint Manufacturing Partnership (“JMP”) to produce DehydraTECH(TM) commercial products under a new brand, which will be announced. The JMP will produce processed THC cannabis and/or CBD hemp powder for new consumer products under categories including, among others, tablets, capsules, or packets for sale in Canada and for export where permitted. Similar powders as a bulk ingredient for manufacturing processes will…

Continue Reading

WednesdayJul 24, 2019 9:28 am

CBDNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Finalizes Acquisition of Zoots Premium Cannabis Infused Edibles

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) this morning announced the successful completion of its acquisition of Washington-based Natural Extractions, Inc. d/b/a Zoots Premium Cannabis Infused Edibles. The total consideration for the purchase of Zoots is approximately US $11 million, comprised of US $855,000 cash and issuance of 9,635,150 common shares at C$1.30 per share to the vendors of Zoots, and the assumption of US $606,420 in outstanding debt. Additionally, the vendors have agreed to a lock-up agreement whereby up to 70% of the consideration shares are released over nine months. IONIC will also issue to the shareholders of…

Continue Reading

TuesdayJul 23, 2019 3:08 pm

CBDNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Joint Development Agreement to Create Biosynthesis Platform for CBD Production, Distribution

Willow Biosciences (CSE: WLLW) recently entered a joint development agreement (“JDA”) with leading cannabinoid manufacturer Noramco Inc. to develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (“CBD”) (http://cnw.fm/KZdi0). An article further discussing the company reads, “The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skill sets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under the agreement.…

Continue Reading

TuesdayJul 23, 2019 2:51 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human body can only absorb a small amount of the molecules. DehydraTECH is disrupting this cycle by protecting the product during stomach transit, amplifying intestinal absorption by five to ten times over traditional methods and enabling the drug to bypass first-pass liver metabolism. Third-party lab studies…

Continue Reading

TuesdayJul 23, 2019 12:09 pm

CBDNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Investment Platform Targets UK, European CBD Health and Wellness Sector

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently launched a new investment platform called Supreme Heights. Established in London, the platform will capitalize on opportunities within the UK and European CBD health-and-wellness space. An article discussing the company reads, “While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://cnw.fm/WgJ6O). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and…

Continue Reading

TuesdayJul 23, 2019 9:40 am

CBDNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Prelaunch of Viva Buds Inc.

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, this morning announced the prelaunch of cannabis delivery service Viva Buds Inc. in the San Fernando Valley in Los Angeles, California, with sign-ups now available on its website. MCOA and Natural Plant Extracts of California (“NPE”) established a joint venture (“JV”) in March to form Viva Buds, sharing the net profits on a 50-50 basis. NPE is responsible for managing all operations relating to distribution, manufacturing and delivery of cannabis products, and MCOA will provide capital, consulting and marketing services. The staff and marketing team of Viva Buds…

Continue Reading

MondayJul 22, 2019 10:31 am

CBDNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Completes Investment in Applied Cannabis Sciences of New Jersey

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that, through a wholly owned U.S. subsidiary, it has finalized its investment into Applied Cannabis Sciences of New Jersey ("ACS"). The investment was previously announced in an April 15, 2019, press release as a letter of intent. According to the update, ACS will submit its application in the upcoming New Jersey round of Request for Applications (“RFA”), through which the state will issue 24 new permits comprising of 15 dispensary permits, 5 cultivation permits and 4 vertically integrated permits. "Completing this investment with ACS and being on the ground floor…

Continue Reading

MondayJul 22, 2019 9:40 am

CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces PharmHouse JV’s Receipt of Health Canada Cultivation License

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations in 190,000 sq. ft of licensed nursery infrastructure. In addition, the company plans to ramp up its entire 1.3 million sq. ft of ultramodern greenhouse space before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products, both domestically and internationally, for Canopy Rivers’ ecosystem of partners. "This is a significant corporate milestone for Canopy Rivers. We believe the PharmHouse platform…

Continue Reading

FridayJul 19, 2019 3:44 pm

CBDNewsBreaks – Hemptown USA Employs Strategic Hemp-Cultivation Methodology to Increase Yields, Lower Costs

Hemptown USA is employing technology to improve hemp cultivation by keeping production costs low and optimizing yields. An article discussing the company reads, “Hemptown employs a ‘soil to oil’ methodology that involves experienced professionals working in a few selected agricultural microclimates across Oregon’s Emerald Triangle, Kentucky and Colorado. In 2018, Hemptown harvested 110,000 pounds of full-spectrum biomass with CBD content of approximately 17% from the Oregon hemp farm. . . . In 2019, the company is scaling up operations to meet the growing market demand for affordable hemp and CBD oil. As per initial estimates, it will cultivate over one…

Continue Reading

FridayJul 19, 2019 2:58 pm

CBDNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to provide…

Continue Reading